Transcriptomics and magnetic resonance imaging in major psychiatric disorders

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Major psychiatric disorders represent a significant public health challenge, contributing heavily to national disease burden.
• Identifying reliable biomarkers is crucial for advancing biological psychiatry and understanding these complex conditions.
• Multi-omics approaches, particularly combining genetic data with neuroimaging, are key to elucidating disease pathogenesis.

Purpose of the Study:

• To review and synthesize findings from transcriptomics and magnetic resonance imaging studies over the past decade in major psychiatric disorders.
• To demonstrate the neurobiological mechanisms underlying genetically related structural and functional brain alterations.
• To explore novel avenues for developing quantifiable objective biomarkers for clinical use.

Main Methods:

• Combined transcriptomics (gene expression analysis) and magnetic resonance imaging (MRI) techniques.
• Analysis of structural and functional brain changes in individuals with major psychiatric disorders.
• Integration of multi-omics data across different scales.

Main Results:

• Demonstrated neurobiological mechanisms linking genetic factors to structural and functional brain alterations in psychiatric disorders.
• Identified specific patterns of brain changes associated with genetic predispositions in conditions like depression, bipolar disorder, and schizophrenia.
• Highlighted the utility of combined transcriptomics and MRI in understanding disease complexity.

Conclusions:

• Combined transcriptomics and MRI offer powerful insights into the neurobiology of major psychiatric disorders.
• This integrated approach facilitates the development of objective, quantifiable biomarkers for diagnosis and prognosis.
• Future research can leverage these findings to improve clinical outcomes for patients with psychiatric conditions.